← Top stories
Deal● Neutral for Indian equities
Nanexa shares surge on €1.17 billion Novo Nordisk licensing deal
The brief
- Nanexa shares more than doubled after announcing the drug-delivery licensing deal
- The deal concerns Nanexa’s injection technology